|
|
Post by cjc04 on Feb 9, 2016 10:31:03 GMT -5
Matt said that the Clamp study results were quite good. He also said, a couple of times, that they would be released at the ADA in June. I thought this was interesting for a few reasons. Why wait til June, and why is he already so set on that date? What does he know about Afrezza's presents at the ADA that he already has a plan to release the results there? Considering June is very close to the 2nd half of 2016, how, or what, does he know that MNKD will still be financially stable to have a plan for the ADA?
Not trying to speculate too much, but I just thought his confidence on this was at least interesting.
|
|
|
|
Post by boomboom on Feb 9, 2016 10:41:42 GMT -5
Matt said that the Clamp study results were quite good. He also said, a couple of times, that they would be released at the ADA in June. I thought this was interesting for a few reasons. Why wait til June, and why is he already so set on that date? What does he know about Afrezza's presents at the ADA that he already has a plan to release the results there? Considering June is very close to the 2nd half of 2016, how, or what, does he know that MNKD will still be financially stable to have a plan for the ADA? Not trying to speculate too much, but I just thought his confidence on this was at least interesting. If this was any other company I would have agreed this was indeed an interesting sign from our CEO. But after doing some reflection after what has occurred the past couple of months, there has been confidence exuded in Matt's voice in all of 2015 for things that have completely fallen through. It's his job to instill confidence in investors regardless of what he knows. |
|
|
|
Post by peppy on Feb 9, 2016 10:42:38 GMT -5
cjc04, it is sanofi study.
Mnkd will get it april, may, June?
|
|
|
|
Post by dreamboatcruise on Feb 9, 2016 10:51:45 GMT -5
Matt said that the Clamp study results were quite good. He also said, a couple of times, that they would be released at the ADA in June. I thought this was interesting for a few reasons. Why wait til June, and why is he already so set on that date? What does he know about Afrezza's presents at the ADA that he already has a plan to release the results there? Considering June is very close to the 2nd half of 2016, how, or what, does he know that MNKD will still be financially stable to have a plan for the ADA? Not trying to speculate too much, but I just thought his confidence on this was at least interesting. I've had experience at companies with cash flow problems. You don't stop your normal business unless you absolutely have to. MNKD/SNY decided to present these results at ADA, which makes sense because it is very prestigious and draws a lot of people, and they wouldn't change that. I don't think it shows any particular confidence... just carrying on with plans unless forced to do otherwise. These results aren't going to be anything earth shattering, since they are basically just repeating and expanding upon clamp studies already performed. |
|
|
|
Post by lorcan458 on Feb 9, 2016 11:02:44 GMT -5
He said why in the last call. The conference specifically asked for the results to be released at the conference and not beforehand.
|
|
|
|
Post by dreamboatcruise on Feb 9, 2016 11:18:01 GMT -5
lorcan458... I don't remember the exact wording, but I'd suspect what was meant was that ADA has that policy rather than specifically asking MNKD. It isn't unusual for a conference to require that results be new, not previously published.
|
|
|
|
Post by kc on Feb 9, 2016 15:04:04 GMT -5
He said why in the last call. The conference specifically asked for the results to be released at the conference and not beforehand. That is the place for technical papers to be released and discussed to the ENDO market. 2nd point is that will be the place where MannKind roles out who their USA distribution partner will be or perhaps new owner? You just never know until it happens. |
|
|
|
Post by bradleysbest on Feb 9, 2016 17:38:30 GMT -5
Is there an annual Endo convention (specifically for them) or do they get lumped in with other medical conventions? MNKD needs to get these folks educated on the results they have seen so far. Bring in the heavy hitters (Sam, Spiro, Peakabull) & show them their actual results from using Afrezza.
|
|
|
|
Post by BlueCat on Feb 9, 2016 17:41:58 GMT -5
Is there an annual Endo convention (specifically for them) or do they get lumped in with other medical conventions? MNKD needs to get these folks educated on the results they have seen so far. Bring in the heavy hitters (Sam, Spiro, Peakabull) & show them their actual results from using Afrezza. And that they are still breathing fine. |
|
|
|
Post by liane on Feb 9, 2016 17:57:09 GMT -5
|
|
|
|
Post by nylefty on Feb 9, 2016 18:27:49 GMT -5
Is there an annual Endo convention (specifically for them) or do they get lumped in with other medical conventions? MNKD needs to get these folks educated on the results they have seen so far. Bring in the heavy hitters (Sam, Spiro, Peakabull) & show them their actual results from using Afrezza. Can MannKind "bring in" users to say what MannKind can't say because of FDA restrictions? I don't think so. |
|
|
|
Post by mnholdem on Feb 10, 2016 5:58:38 GMT -5
It's important that results are released in a peer reviewed publication. Hopefully, MannKind had some say in this process because I don't trust Sanofi to ensure that Afrezza study results are shown in the best light.
|
|
|
|
Post by mindovermatter on Feb 10, 2016 7:14:58 GMT -5
It's important that results are released in a peer reviewed publication. Hopefully, MannKind had some say in this process because I don't trust Sanofi to ensure that Afrezza study results are shown in the best light. Makes sense and is usually the way to roll out trial data. But, will it matter? Will the clamp data results make endos/pcps change their mind about Afrezza and embrace it as a viable weapon to fight diabetes? I'm not so sure it will. |
|
|
|
Post by saxcmann on Feb 10, 2016 9:13:52 GMT -5
It's important that results are released in a peer reviewed publication. Hopefully, MannKind had some say in this process because I don't trust Sanofi to ensure that Afrezza study results are shown in the best light. Makes sense and is usually the way to roll out trial data. But, will it matter? Will the clamp data results make endos/pcps change their mind about Afrezza and embrace it as a viable weapon to fight diabetes? I'm not so sure it will. I hear scientific data is very important and how it is released. Positive clamp results would influence endos/pcps strongly. Currently data is insufficient. Doctor education and DTC marketing will also be very important for success,imo. |
|
|
|
Post by esstan2001 on Feb 10, 2016 9:35:25 GMT -5
Is there an annual Endo convention (specifically for them) or do they get lumped in with other medical conventions? MNKD needs to get these folks educated on the results they have seen so far. Bring in the heavy hitters (Sam, Spiro, Peakabull) & show them their actual results from using Afrezza. Can MannKind "bring in" users to say what MannKind can't say because of FDA restrictions? I don't think so. said users can come in on their own nickel and say what they want, if someone sets up some type of forum for them. AS you allude to, It's just that someone with an interest (mnkd) can not foot the bill. |
|
